219 related articles for article (PubMed ID: 34977031)
1. Mechanisms of Arrhythmogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (
Shafaattalab S; Li AY; Gunawan MG; Kim B; Jayousi F; Maaref Y; Song Z; Weiss JN; Solaro RJ; Qu Z; Tibbits GF
Front Cell Dev Biol; 2021; 9():787581. PubMed ID: 34977031
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.
Wang L; Kim K; Parikh S; Cadar AG; Bersell KR; He H; Pinto JR; Kryshtal DO; Knollmann BC
J Mol Cell Cardiol; 2018 Jan; 114():320-327. PubMed ID: 29217433
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Pathogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant R278C
Shafaattalab S; Li AY; Jayousi F; Maaref Y; Dababneh S; Hamledari H; Baygi DH; Barszczewski T; Ruprai B; Jannati S; Nagalingam R; Cool AM; Langa P; Chiao M; Roston T; Solaro RJ; Sanatani S; Toepfer C; Lindert S; Lange P; Tibbits GF
bioRxiv; 2023 Aug; ():. PubMed ID: 37609317
[TBL] [Abstract][Full Text] [Related]
4. In vitro analyses of suspected arrhythmogenic thin filament variants as a cause of sudden cardiac death in infants.
Shafaattalab S; Li AY; Lin E; Stevens CM; Dewar LJ; Lynn FC; Sanatani S; Laksman Z; Morin RD; van Petegem F; Hove-Madsen L; Tieleman DP; Davis JP; Tibbits GF
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6969-6974. PubMed ID: 30886088
[TBL] [Abstract][Full Text] [Related]
5. Low expression of the K280N
Sequeira V; Wang L; Wijnker PJM; Kim K; Pinto JR; Dos Remedios C; Redwood C; Knollmann BC; van der Velden J
J Mol Cell Cardiol Plus; 2022 Sep; 1():100007. PubMed ID: 37159677
[TBL] [Abstract][Full Text] [Related]
6. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for
Kondo T; Higo S; Shiba M; Kohama Y; Kameda S; Tabata T; Inoue H; Okuno S; Ogawa S; Nakamura S; Takeda M; Ito E; Li J; Liu L; Kuramoto Y; Lee JK; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Circ Genom Precis Med; 2022 Oct; 15(5):e003522. PubMed ID: 35861968
[TBL] [Abstract][Full Text] [Related]
7. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
Knollmann BC; Kirchhof P; Sirenko SG; Degen H; Greene AE; Schober T; Mackow JC; Fabritz L; Potter JD; Morad M
Circ Res; 2003 Mar; 92(4):428-36. PubMed ID: 12600890
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic troponin T mutants with opposing effects on myofilament Ca
Dieseldorff Jones KM; Koh Y; Weller RS; Turna RS; Ahmad F; Huke S; Knollmann BC; Pinto JR; Hwang HS
Arch Biochem Biophys; 2019 Jan; 661():125-131. PubMed ID: 30445044
[TBL] [Abstract][Full Text] [Related]
9. Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes.
Schuldt M; Johnston JR; He H; Huurman R; Pei J; Harakalova M; Poggesi C; Michels M; Kuster DWD; Pinto JR; van der Velden J
J Mol Cell Cardiol; 2021 Jan; 150():77-90. PubMed ID: 33148509
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium-glucose cotransporter 2 inhibitors.
Wijnker PJM; Dinani R; van der Laan NC; Algül S; Knollmann BC; Verkerk AO; Remme CA; Zuurbier CJ; Kuster DWD; van der Velden J
Cardiovasc Res; 2024 Mar; 120(3):301-317. PubMed ID: 38240646
[TBL] [Abstract][Full Text] [Related]
11. Translational investigation of electrophysiology in hypertrophic cardiomyopathy.
Flenner F; Jungen C; Küpker N; Ibel A; Kruse M; Koivumäki JT; Rinas A; Zech ATL; Rhoden A; Wijnker PJM; Lemoine MD; Steenpass A; Girdauskas E; Eschenhagen T; Meyer C; van der Velden J; Patten-Hamel M; Christ T; Carrier L
J Mol Cell Cardiol; 2021 Aug; 157():77-89. PubMed ID: 33957110
[TBL] [Abstract][Full Text] [Related]
12. Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy.
Knollmann BC; Blatt SA; Horton K; de Freitas F; Miller T; Bell M; Housmans PR; Weissman NJ; Morad M; Potter JD
J Biol Chem; 2001 Mar; 276(13):10039-48. PubMed ID: 11113119
[TBL] [Abstract][Full Text] [Related]
13. Increased cytosolic calcium buffering contributes to a cellular arrhythmogenic substrate in iPSC-cardiomyocytes from patients with dilated cardiomyopathy.
Jung P; Seibertz F; Fakuade FE; Ignatyeva N; Sampathkumar S; Ritter M; Li H; Mason FE; Ebert A; Voigt N
Basic Res Cardiol; 2022 May; 117(1):5. PubMed ID: 35499658
[TBL] [Abstract][Full Text] [Related]
14. Cardiac troponin T N-domain variant destabilizes the actin interface resulting in disturbed myofilament function.
Landim-Vieira M; Ma W; Song T; Rastegarpouyani H; Gong H; Coscarella IL; Bogaards SJP; Conijn SP; Ottenheijm CAC; Hwang HS; Papadaki M; Knollmann BC; Sadayappan S; Irving TC; Galkin VE; Chase PB; Pinto JR
Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2221244120. PubMed ID: 37252999
[TBL] [Abstract][Full Text] [Related]
15. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.
Wu H; Yang H; Rhee JW; Zhang JZ; Lam CK; Sallam K; Chang ACY; Ma N; Lee J; Zhang H; Blau HM; Bers DM; Wu JC
Eur Heart J; 2019 Dec; 40(45):3685-3695. PubMed ID: 31219556
[TBL] [Abstract][Full Text] [Related]
16. Development of a Cardiac Sarcomere Functional Genomics Platform to Enable Scalable Interrogation of Human
Pettinato AM; Ladha FA; Mellert DJ; Legere N; Cohn R; Romano R; Thakar K; Chen YS; Hinson JT
Circulation; 2020 Dec; 142(23):2262-2275. PubMed ID: 33025817
[TBL] [Abstract][Full Text] [Related]
17. Establishing a new human hypertrophic cardiomyopathy-specific model using human embryonic stem cells.
Cai H; Li B; Bai A; Huang J; Zhan Y; Sun N; Liang Q; Xu C
Exp Cell Res; 2020 Feb; 387(1):111736. PubMed ID: 31759053
[TBL] [Abstract][Full Text] [Related]
18. Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency.
Pioner JM; Santini L; Palandri C; Langione M; Grandinetti B; Querceto S; Martella D; Mazzantini C; Scellini B; Giammarino L; Lupi F; Mazzarotto F; Gowran A; Rovina D; Santoro R; Pompilio G; Tesi C; Parmeggiani C; Regnier M; Cerbai E; Mack DL; Poggesi C; Ferrantini C; Coppini R
Front Physiol; 2022; 13():1030920. PubMed ID: 36419836
[TBL] [Abstract][Full Text] [Related]
19. Genetic Studies of Hypertrophic Cardiomyopathy in Singaporeans Identify Variants in
Pua CJ; Tham N; Chin CWL; Walsh R; Khor CC; Toepfer CN; Repetti GG; Garfinkel AC; Ewoldt JF; Cloonan P; Chen CS; Lim SQ; Cai J; Loo LY; Kong SC; Chiang CWK; Whiffin N; de Marvao A; Lio PM; Hii AA; Yang CX; Le TT; Bylstra Y; Lim WK; Teo JX; Padilha K; Silva GV; Pan B; Govind R; Buchan RJ; Barton PJR; Tan P; Foo R; Yip JWL; Wong RCC; Chan WX; Pereira AC; Tang HC; Jamuar SS; Ware JS; Seidman JG; Seidman CE; Cook SA
Circ Genom Precis Med; 2020 Oct; 13(5):424-434. PubMed ID: 32815737
[TBL] [Abstract][Full Text] [Related]
20. Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia.
Schober T; Huke S; Venkataraman R; Gryshchenko O; Kryshtal D; Hwang HS; Baudenbacher FJ; Knollmann BC
Circ Res; 2012 Jul; 111(2):170-9. PubMed ID: 22647877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
